New patent for the drug XERIS GVOKE HYPOPEN – DrugPatentWatch
Annual Drug Patent Expiration for GVOKE+HYPOPEN
Gvoke Hypopen is a drug marketed by Xeris and included in one NDA. It is available from a single supplier. There is one patent protecting this drug.
GVOKE HYPOPEN drug price trends.
This drug has eighteen patent family members in thirteen countries.
The generic ingredient in GVOKE HYPOPEN is glucagon. One registered supplier for this compound. Additional details are available on the glucagon profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug XERIS GVOKE HYPOPEN
